Home » Topics » Regulatory » Patents

Patents
RSS

Taiho discloses antitumor nucleoside drugs

Aug. 23, 1996

Cyclooxygenase-2-inhibitors described by Japan Tobacco

Aug. 23, 1996

Cyclooxygenase-2 inhibitors from Merck Frosst

Aug. 23, 1996

Protease inhibitors from Sankyo

Aug. 23, 1996

SmithKline Beecham describes protease inhibitors

Aug. 23, 1996

Takeda describes cephem antibacterial agents

Aug. 23, 1996

More tachykinin NK1 antagonists reported by Sandoz

Aug. 23, 1996

Coagulation factor X inhibitors described by Yamanouchi

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

Sanofi describes fibrinogen antagonists

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...